RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kainos Laboratories - Stock

Kainos Laboratories ROA 2024

Kainos Laboratories ROA

0.07

Ticker

4556.T

ISIN

JP3205650009

In 2024, Kainos Laboratories's return on assets (ROA) was 0.07, a 9.74% increase from the 0.07 ROA in the previous year.

Kainos Laboratories Aktienanalyse

What does Kainos Laboratories do?

Kainos Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Kainos Laboratories's Return on Assets (ROA)

Kainos Laboratories's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Kainos Laboratories's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Kainos Laboratories's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Kainos Laboratories’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Kainos Laboratories Stock

What is the Return on Assets (ROA) of Kainos Laboratories this year?

The Return on Assets (ROA) of Kainos Laboratories is 0.07 undefined this year.

What was the ROA of Kainos Laboratories compared to the previous year?

The ROA of Kainos Laboratories has increased by 9.74% compared to the previous year.

What consequences do high ROA have for investors of Kainos Laboratories?

A high ROA is advantageous for investors of Kainos Laboratories, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Kainos Laboratories?

A low ROA can be unfavorable for investors of Kainos Laboratories as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Kainos Laboratories affect the company?

An increase in ROA of Kainos Laboratories can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Kainos Laboratories impact the company?

A reduction in the ROA of Kainos Laboratories can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Kainos Laboratories?

Some factors that can influence the ROA of Kainos Laboratories include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Kainos Laboratories important for investors?

The ROA of Kainos Laboratories is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Kainos Laboratories take to improve ROA?

To improve ROA, Kainos Laboratories can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Kainos Laboratories pay?

Over the past 12 months, Kainos Laboratories paid a dividend of 32 JPY . This corresponds to a dividend yield of about 2.7 %. For the coming 12 months, Kainos Laboratories is expected to pay a dividend of 32 JPY.

What is the dividend yield of Kainos Laboratories?

The current dividend yield of Kainos Laboratories is 2.7 %.

When does Kainos Laboratories pay dividends?

Kainos Laboratories pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Kainos Laboratories?

Kainos Laboratories paid dividends every year for the past 16 years.

What is the dividend of Kainos Laboratories?

For the upcoming 12 months, dividends amounting to 32 JPY are expected. This corresponds to a dividend yield of 2.7 %.

In which sector is Kainos Laboratories located?

Kainos Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kainos Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kainos Laboratories from 6/1/2024 amounting to 32 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did Kainos Laboratories pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of Kainos Laboratories in the year 2023?

In the year 2023, Kainos Laboratories distributed 25 JPY as dividends.

In which currency does Kainos Laboratories pay out the dividend?

The dividends of Kainos Laboratories are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kainos Laboratories

Our stock analysis for Kainos Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kainos Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.